Another restructuring is underway at bluebird bio Inc., this time with plans to lay off about 25% of the Somerville company’s workforce.
Bluebird said Tuesday that the latest cuts are part of its plan to achieve quarterly cash flow break-even in the second half of 2025. Bluebird noted that the restructuring is expected to result in a 20% reduction in cash operating expenses when fully realized in Q3 2025, compared to the prior reporting period.
WATCH ANYTIME FOR FREE
 |
>Stream NBC10 Boston news for free, 24/7, wherever you are. |
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our >News Headlines newsletter.
Copyright Boston Business Journal
